Conversations in Drug Development Trends

NOVEMBER 5, 2024

In preparation for World Orphan Drug Congress Europe, we interviewed Nathan Chadwick, Senior Director, Therapeutic Strategy Lead, Rare Disease, and Derek Ansel, MS, LCGC, Vice President, Therapeutic Strategy Lead, Rare Disease, to hear their insights into the current progress in rare disease research and their hopes for 2025.

Disease 52

Disease Clinical Trials Therapies Clinical Research 52

Fierce BioTech

JUNE 11, 2025

From Fragments To Clarity: Empowering Research with Complete Patient Data Learn how natural language processing (NLP) unlocks critical insights from unstructured EHR data—like physician notes and patient narratives—to give researchers a complete view of the patient journey. Download now. Download now. Download now.

Research 52

Research Drug Development Drugs 52

Drug Target Review

JUNE 11, 2025

Drug development is plagued by complex challenges, but multimodal AI is unlocking new opportunities. By integrating diverse data sources – from genomics to clinical insights – this approach is accelerating drug discovery, improving patient stratification and boosting success rates. Highlighting data integration.

Drugs 64

Drugs Clinical Trials Drug Development Pharmaceuticals 64

Perficient: Drug Development

NOVEMBER 15, 2024

Our experts are closely monitoring eight healthcare trends that are shaping industry leaders’ strategies in 2025. 2025 will see the continued push to meet healthcare consumers’ demand for convenience and personalized digital experiences. And this year is especially interesting, as 2024’s U.S. billion by 2030.

Regulations 64

Regulations Compliance Production Nurses 64

The Pharma Data

JUNE 26, 2025

Located in Jiangsu Province, China, the Nantong site serves as a critical component of WuXi AppTec’s expansive Contract Research, Development, and Manufacturing Organization (CRDMO) platform. For instance, the layout fosters natural daylighting, open communication channels, and physical proximity among different research units.

Laboratories 40

Laboratories Science Pharmaceuticals Compliance 40

The Premier Consulting Blog

APRIL 13, 2025

On April 10, 2025, the US FDA announced that it has a long-term plan to eliminate conventional animal testing in drug development, starting with monoclonal antibodies (mAbs).[ One great example is the FDAs 505(b)(2) New Drug Application (NDA) pathway. 7] This was a landmark change in philosophy.

Animal Testing 52

Animal Testing FDA Drug Development Production 52

Perficient: Drug Development

NOVEMBER 15, 2024

Our experts are closely monitoring eight healthcare trends that are shaping industry leaders’ strategies in 2025. 2025 will see the continued push to meet healthcare consumers’ demand for convenience and personalized digital experiences. And this year is especially interesting, as 2024’s U.S. billion by 2030.

Regulations 52

Regulations Compliance Production Nurses 52

FDA Law Blog: Biosimilars

APRIL 8, 2025

About one third of these PSGs are for complex products and many reflect what OGD and DPD learned about the science of equivalence from GDUFA-funded regulatory science research. Leading FDAs implementationof the Drug Competition Action Plan (DCAP). facilitating the twice annual updates to the Off-Patent, Off-Exclusivity List ).

FDA 144

FDA Drugs Production Drug Development 144

Perficient: Drug Development

JUNE 3, 2025

As we move through 2025, artificial intelligence especially generative AI continues to redefine how enterprises operate and compete. AI Technical Services Landscape Forresters AI Technical Services Landscape, Q2 2025 report provides an overview of 36 notable providers in the rapidly evolving AI services market.

Government 72

Government Engineering Production Pharmaceuticals 72

The Pharma Data

JUNE 26, 2025

BeOne Medicines Showcases Bold Vision and Expansive Oncology Pipeline at 2025 R&D Day BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, delivered a comprehensive update to investors today during its highly anticipated Research and Development (R&D) Day. Global Head of R&D. “We

Research 40

Research Clinical Development Clinical Trials Engineering 40

Drug Target Review

JULY 8, 2025

As Vice President of Oncology Early Development (OED) at AbbVie , she leads the charge on translating bold scientific ideas into real-world impact – and she’s doing it with a focus on some of the most tenacious cancers out there. Her team sits right at the edge of innovation, where discovery science meets clinical execution.

Therapies 52

Therapies Science Drug Development Treatment 52

FDA Law Blog: Drug Discovery

FEBRUARY 27, 2025

Livornese As anticipated, the International Council for Harmonization (ICH) published the Good Clinical Practice (GCP) guideline E6(R3) Principles and Annex 1 on January 6, 2025. While ICH E6(R3) was still in the development phase, the FDA released a draft guidance in May 2023 in the form of the draft ICH E6(R3).

Clinical Trials 88

Clinical Trials Trials Clinical Research Government 88

New Drug Approvals

APRIL 2, 2025

1] [2] It was developed by Vertex Pharmaceuticals , [5] and was approved for medical use in the United States in January 2025. [2] 2] [6] Suzetrigine is the first medication to be approved by the US Food and Drug Administration (FDA) in this new class of pain management medicines. [2] 6 February 2025. ESI-MS m/z calc.475.0922,

FDA 62

FDA Therapies Trials Treatment 62

Alta Sciences

MARCH 4, 2025

Forging a Path Forward for Substance Abuse Potential Studies With the Cross-Company Abuse Liability Council By Beatrice Setnik, PhD pmjackson Tue, 03/04/2025 - 20:10 Many of my colleagues and I are members of the Cross-Company Abuse Liability Council (CCALC), where I have been a co-chair for the past seven years, and a member for 15.

Clinical Trials 52

Clinical Trials FDA Drug Development Trials 52

Plenge Gen

JANUARY 7, 2025

My message was that AI-enabled drug discovery was comingsomeday. Fast forward to 2025, and that someday is now. … The post AI Unleashed: Transforming Drug Discovery from Theory to Practice appeared first on Plenge Gen @rplenge. Weve seen an explosion in the availability and capability of AI tools.

Drugs 52

Drugs Production Research Drug Development 52

H1 Blog

OCTOBER 30, 2023

The application of AI in the life sciences sector has the potential to revolutionize many aspects of research, development, and patient care. By 2025, we can anticipate pretty significant shifts as AI continues to advance and integrate into various processes within the healthcare ecosystem.

Science 59

Science Clinical Trials Trials Engineering 59

Perficient: Drug Development

APRIL 18, 2025

Understanding the Providers Forrester meticulously researched each service provider through a comprehensive set of questions. Access the Forrester report, The Digital Transformation Services Landscape, Q2 2025 to find out more. Information is based on the best available resources.

Production 64

Production Government Research Marketing 64

The Pharma Data

JUNE 18, 2025

Pushkal Garg to Lead Unified Research and Development Organization, Signaling Strategic Expansion into Next Phase of RNAi Therapeutics Innovation Alnylam Pharmaceuticals , a global leader in RNA interference (RNAi) therapeutics, has announced the promotion of Pushkal Garg, M.D., He holds a B.A.

RNA 40

RNA Clinical Development Science Disease 40

Alta Sciences

JUNE 6, 2025

Case Study: Two Examples of Successful Automation Integration at Altasciences for Pharmacokinetic Studies pmjackson Fri, 06/06/2025 - 09:01 By Martin Rougée, Optimization Scientist, Bioanalytical Operations Automation offers several advantages to any industry. Tags Bioanalysis Preclinical Research Weight 15

Pharmacokinetics 52

Pharmacokinetics Molecular Biology Drug Development Pharmaceutical Companies 52

Drug Target Review

JUNE 16, 2025

1 Continuous advancements in sensitivity and spatial resolution support the role of MSI in pharmaceutical research. By complementing traditional analytical methods, it provides a more accurate representation of drug behaviour to support translational and pre-clinical studies. Drug Discovery Today 2025, 30 (1), 104275.

Drugs 52

Drugs Organic Chemistry Laboratories Pharmaceuticals 52

BioPharma Drive: Drug Pricing

JUNE 23, 2025

Understanding GLP-1 drugs GLP-1, or glucagon-like peptide-1 receptor modulators, mimic natural hormones that regulate insulin and appetite. Ben explained that while these medications were first designed for blood sugar control, researchers quickly realized their powerful potential for weight loss.

Treatment 130

Treatment Drugs Therapies FDA 130

Alta Sciences

JUNE 26, 2025

All Rights Reserved. Cookie Policy | Privacy Policy Have a question? × Id be happy to help. No, thanks. Captcha is required.

Pharmacokinetics 40

Pharmacokinetics Testimonials Biosimilars Drug Development 40

Alta Sciences

JUNE 26, 2025

All Rights Reserved. Cookie Policy | Privacy Policy Have a question? × Id be happy to help. No, thanks. Captcha is required.

Pharmacokinetics 40

Pharmacokinetics Testimonials Biosimilars Drug Development 40

Drug Target Review

JANUARY 8, 2024

We are at the forefront of drug development in an area of research called cellular rejuvenation, which is an approach that has the potential to address many diseases of ageing by restoring aged and injured cells to a more youthful and resilient state.

Science 145

Science Disease FDA Approval Pharmaceutical Companies 145

Perficient: Drug Development

APRIL 25, 2025

This dedication was recognized by the Business Intelligence Groups 2025 Excellence in Customer Service Awards, where Perficient proudly claimed the title of Organization of the Year in the Internet and Technology category.

Engineering 52

Engineering Research 52

PPD

NOVEMBER 30, 2023

As we approach the end of 2023, it’s time to reflect on the past 12 months and how advances in drug development shaped the pharma and biotech industries. Five Predictions for the Drug Development Industry in 2024 1. These shifts are a prelude to further change and progress in the clinical trial landscape in 2024.

Clinical Trials 98

Clinical Trials Trials Clinical Research Drug Development 98

FDA Law Blog: Drug Discovery

MARCH 3, 2025

The American Conference Institutes 3rd Annual Forum on Advanced Therapeutics is scheduled to take place from March 19-20, 2025, at the Seaport Hotel in Boston, MA. Attend to engage with leading industry thought leaders and legal pioneers who will illuminate the path from groundbreaking research to global market success.

Compliance 52

Compliance FDA Marketing Therapies 52

Alta Sciences

FEBRUARY 10, 2025

Let Us Guide You Through the Process blussier Mon, 02/10/2025 - 17:54 HTML Let Us Guide You Through the Process Altasciences' experts streamline the IND/CTA application process by designing your regulatory strategy and thoroughly planning and completing your required preclinical studies.

Small Molecule 52

Small Molecule Clinical Trials Drug Development Trials 52

Fierce BioTech

JANUARY 15, 2025

This powerful combination is providing the scientific community with unprecedented capabilities to tackle biological complexity and improve our understanding of the mechanisms underlying cancer development. Join us to learn how this technological convergence is reshaping the landscape of drug development and precision medicine.

Drug Development 52

Drug Development Treatment Research Drugs 52

Perficient: Drug Development

FEBRUARY 27, 2025

trillion in disposable income according to research by the Return on Disability Group. Actions to start in 2025 Its never too late to gain ground on competitive brands, and particularly brands with no foothold with these two consumer groups. And this form of research can be quite affordable and effective. In the U.S.

Compliance 52

Compliance Research Marketing Production 52

Perficient: Drug Development

MAY 21, 2025

Explore a few of our recent analyst relations inclusions: Forrester featured Perficients AI expertise in its Design GenAI-Powered Experiences Responsibly, Q1 2025 Report , which discussed ensuring Generative AI solutions are functional, efficient, and safe.

Marketing 69

Marketing Production Research 69

ACTO

DECEMBER 17, 2024

A survey of healthcare and life science companies found that 93% of these companies expect to increase their spend in 2025. These councils bring together diverse expertise from scientists and researchers, data analysts and technology specialists, regulatory compliance experts, as well as commercial operations leaders.

Government 52

Government Compliance Pharmaceutical Companies Pharmaceuticals 52

Fierce BioTech

DECEMBER 23, 2024

First-in-Human, Drug-Drug Interaction, Food Effect, Bioequivalence, etc.), and often require consistent batches of drug product be administered to groups of research participants within a short timeframe, early phase studies present unique challenges for drug developers not typically experienced in later stages of development.

Pharmacy 52

Pharmacy Trials Clinical Trials Clinical Development 52

Alta Sciences

JULY 3, 2025

All Rights Reserved. Cookie Policy | Privacy Policy Have a question? × Id be happy to help. No, thanks. Captcha is required.

Marketing 40

Marketing Pharmacokinetics Testimonials Biosimilars 40

Alta Sciences

APRIL 10, 2025

Altasciences is committed to using cutting-edge technology to support its ocular research. From comprehensive ocular assessments to complex surgical interventions, Altasciences is equipped to handle the full spectrum of ophthalmic research needs. Learn more about our comprehensive ophthalmic drug development services!

Clinical Pharmacology 52

Clinical Pharmacology Drug Development Drugs Research 52

Drug Target Review

JUNE 5, 2025

Expanding access and impact A major step forwards came in February 2025 with the announcement of the BET on Blood for SCD partnership between the National Alliance of Sickle Cell Centers (NASCC) and Terumo Blood and Cell Technologies. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.Available Sickle Cell Anemia.

Disease 52

Disease Treatment Therapies Nurses 52

Perficient: Drug Development

APRIL 17, 2025

This blog series celebrates Perficients recognition as a 2025 USA Today Top Workplace. O ur life sciences team is d e dicate d to supporting clients in the pharmaceutical, biotechnology, medical technology , and contract research organization sectors.

Science 64

Science Compliance Production Pharmaceuticals 64